Hyperdrive Science

Speeding up the journey to health

Through improved accuracy of drug candidate selection.

The biggest challenge faced by pharmaceutical companies worldwide is the time and cost involved in developing drugs in order for them to save lives and alleviate suffering. Through tests we can see what the result of a drug is, but not necessarily the why – to which protein does the drug target bind in order to get that result? 

Hyperdrive Science has the solution.

Using technology that takes advantage of naturally occurring processes, Hyperdrive Science finds the specific human protein target related to the drug’s effect without bias in a matter of weeks, to make drug candidate selection more specific, thereby providing a better, faster, and more rational drug selection process. We believe this is very important because it could reduce drug failure rates, deconvolute phenotypic screening results, identify proprietary new drug targets and reposition currently approved drugs for new applications. The rapid access to new target information of any drug candidate allows pharmaceutical companies to make more rational selections and unlock hidden value.

As a technology company, our goal is to make preclinical R&D an easier, more efficient, and cost-effective process to drive a new age of drug discovery for pharmaceutical companies.

We focus on the rapid identification of human targets for drug candidates and high value compounds o interest.

Interested in learning more? Check out our website at Hyperdrive Science – Speeding up the journey to health (csiro.au) for more information and to contact the team.